[Remote] Principal Scientist, Biocompatibility at GE Healthcare

Remote

GE Healthcare Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Medical TechnologyIndustries

Requirements

  • Masters in physical/organic/biochemistry, toxicology, bioengineering, or equivalent material science
  • Expert in ISO 10993 (biological evaluation of medical devices) for surface contact materials and ISO 18562 (biocompatibility evaluation of breathing gas pathways)
  • Experience conducting material and chemical characterization of medical devices, physicochemical analyses of polymeric materials, metals, and ceramics
  • Experience (10+ years) in design and development of medical devices that are categorized as FDA Class II and Class III
  • Experience with residue analyses, biological evaluation, and toxicological risk assessment of medical devices with direct contact (physical contact with body tissue), indirect contact (fluid or gas pathways, prior to tissue contact), and transient contact (brief contact with body tissue); ability to design experiments for and derive thresholds of toxicological concern and tolerable exposure levels
  • Excellent verbal and written communication and presentation skills with the ability to speak and write clearly and convincingly in English, tailoring communication methods to customer’s requirements
  • Advanced experience and proficiency with MS Office word processing, spreadsheet, presentation, and collaboration applications

Responsibilities

  • Serve as a lead scientist for biocompatibility related standards, design requirements, test methods, and interpret test results for the PCS business across its sub-segments, for products such as patient monitors, anesthesia systems, cardiology/ECG, home care, maternal/infant care, and clinical accessories
  • Interface with Patient Care Solutions leadership in advising, developing, and conducting biocompatibility risk assessments, as a key voice in developing product strategy
  • Ensure standardized test methods across multiple material and device types, leveraging common data to derive meaningful conclusions on the potential for toxicological concern
  • Oversee technical approaches (material selections, design, test methods, test execution) for products to ensure they designed according to biocompatibility science and standards, and lead efforts to ensure existing products remain state-of-the-art with such science and standards
  • Evaluate materials for potential cytotoxicity, systemic toxicity, genotoxicity, carcinogenicity, degradation, leachables, or off-gassing; and incorporate adequate requirements to ensure low risk of potential toxicological risk in plastics design guidelines and technical design reviews

Skills

Biocompatibility
Medical Devices
ISO 10993
Toxicology
Cytotoxicity
Systemic Toxicity
Genotoxicity
Risk Assessment
Material Selection
Test Methods
Standards Compliance
Regulatory Affairs

GE Healthcare

Healthcare technology and data analytics provider

About GE Healthcare

GE Healthcare provides a range of healthcare technologies and services aimed at improving patient care. Its main products include imaging systems, mobile diagnostic devices, patient monitoring solutions, and advanced software for data analysis. These products help medical professionals make informed decisions and enhance the efficiency of healthcare delivery. Unlike many competitors, GE Healthcare invests significantly in research and development, allocating $1 billion each year to innovate and enhance its offerings. The company’s goal is to support healthcare providers in delivering better patient outcomes, as evidenced by its technology supporting over 300,000 patients daily and managing 2 billion patient scans each year.

Chicago, IllinoisHeadquarters
1892Year Founded
N/ACompany Stage
Data & Analytics, HealthcareIndustries
10,001+Employees

Risks

Emerging AR technologies increase competition in medical imaging.
Regulatory challenges may delay AI application expansions in healthcare.
Dependence on clinical trial success for new product market positioning.

Differentiation

GE Healthcare invests $1 billion annually in R&D for product innovation.
The company supports over 300,000 patients daily with its healthcare technologies.
GE Healthcare's AIR Recon DL offers 3D motion-insensitive imaging for enhanced MRI quality.

Upsides

Acquisition of Caption Health expands AI-powered ultrasound capabilities.
Successful Phase III trial of [18F]flurpiridaz enhances coronary artery disease detection.
Collaboration with Wayra accelerates digital health innovation in EMEA.

Land your dream remote job 3x faster with AI